New Trade Alert: Solos Endoscopy, Inc. (OTCMKTS: SNDY)
There is one stock I want you to focus on today, because it’s primed for some tremendous potential upside movement:
SNDY is a healthcare instrument company playing in the thriving $133B medical device space. What’s more, the company looks to have just announced two key strategic themes: renewed licensing with the FDA and completed restructuring.
Right now, shares are seeing major technical support along the 50-day simple moving average. And we’ve been seeing obvious signs of increased participation via a ramping average trading volume measure that shouldn’t be missed.
This is all coming in a company that OTC markets reports as running on a float of under 2mm shares, meaning that any kind of influx of new interest could send this thing into orbit
If we start to see that type of buying cascade get traction, the only obvious resistance present above is at the spike along the $0.15 area, putting “the double” well in play on this setup.
In addition, the company recently announced that it has renewed the Establishment Registration & Device Listing of its endoscopic instruments with the FDA (announcement last week.. See Full Press Release Here). That removes some key risks.
In addition, in an effort to clear up the traffic jam in the cap structure, they completed a critical restructuring that may just make shares more attractive than they’ve been in a long, long time.
SNDY (Solos Endoscopy, Inc.), a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions.
SNDYs products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps.
SNDY also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation.
SNDY was formerly known as ViaDux Health and changed its name to in March 2006.
SNDY was founded in 1986 and is based in Boston, Massachusetts.
What You Need To Know:
• SNDY has a small trading float of under 2mm shares, which suggests the stock could launch higher on any additional influx of interest.
• SNDY is making real money, with trailing revs already coming in at $344.78K.
• SNDY is starting to see major topline growth, with quarterly y/y revs increasing at 20%.
• SNDY is coming off an RSI trough under 40, pointing to a massively oversold stock now heading back the other way.
• SNDY is seeing ramping volume after a key hold of support along the 50-day SMA.
For all of these reasons, we are now pounding the table on SNDY. Good luck and Enjoy the Ride!
Don't forget to try my totally free SMS service for real-time alerts. Simply send the message VALUE to the number 33222. If you choose to stop, simply reply STOP.
There are no fees and no spam. Only real-time alerts on highly promising stocks hand-picked for maximum movement.
AI
